13-cis-retinoic acid,Isotretinoin

13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.

Cross Reference

Introduction

To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 13-cis-retinoic acid,Isotretinoin?

13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Acne Vulgaris D000152 35 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 13-cis-retinoic acid,Isotretinoin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 13-cis-retinoic acid,Isotretinoin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

What genes are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 13-cis-retinoic acid,Isotretinoin

Download all related citations
Per page 10 20 50 100 | Total 2952
Authors Title Published Journal PubMed Link
Silva FS et al. The in vitro and in vivo genotoxicity of isotretinoin assessed by cytokinesis blocked micronucleus assay and comet assay. 2013 Toxicol In Vitro pmid:23318729
Mutizwa MM and Sheinbein DM Are we underdosing acne patients with generic isotretinoin? 2013 Dermatol. Online J. pmid:23374954
Raza K et al. Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. 2013 Colloids Surf B Biointerfaces pmid:23357735
Raza K et al. Nano-lipoidal carriers of isotretinoin with anti-aging potential: formulation, characterization and biochemical evaluation. 2013 J Drug Target pmid:23336181
Silva FS et al. The antiestrogen 4-hydroxytamoxifen protects against isotretinoin-induced permeability transition and bioenergetic dysfunction of liver mitochondria: comparison with tamoxifen. 2013 J. Bioenerg. Biomembr. pmid:23779226
Alzoubi KH et al. The effect of genetic polymorphisms of RARA gene on the adverse effects profile of isotretinoin-treated acne patients. 2013 Int J Clin Pharmacol Ther pmid:23782583
Segaran A et al. Pyoderma gangrenosum arising in a breast reduction scar: seven years post-procedure. 2013 J Plast Reconstr Aesthet Surg pmid:23759719
Huoh KC and Chang KW Lip abscess associated with isotretinoin treatment of acne vulgaris. 2013 JAMA Dermatol pmid:23760516
Boyraz N and Mustak PK Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris. 2013 Int. J. Dermatol. pmid:23675954
Crijns I et al. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study. 2013 Expert Opin Drug Saf pmid:23163396
Yılmazer B et al. Bilateral acute sacroiliitis due to isotretinoin therapy: a case report. 2013 Int J Rheum Dis pmid:24164852
Fain K and Alexander GC Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin. 2013 Pharmacoepidemiol Drug Saf pmid:24115318
Prevost N and English JC Isotretinoin: update on controversial issues. 2013 J Pediatr Adolesc Gynecol pmid:24147278
In Brief: Absorica for acne. 2013 Med Lett Drugs Ther pmid:24892143
Webster GF et al. Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study. 2013 J. Am. Acad. Dermatol. pmid:23953888
Dubeau MF et al. Drug-induced inflammatory bowel disease and IBD-like conditions. 2013 Inflamm. Bowel Dis. pmid:22573536
Ustun I et al. Gynecomastia: a rare complication of isoretinoin? 2013 Cutan Ocul Toxicol pmid:22813063
Morales-Cardona CA and Sánchez-Vanegas G Acne relapse rate and predictors of relapse following treatment with oral isotretinoin. 2013 Actas Dermosifiliogr pmid:22795452
D'Erme AM et al. Association between isotretinoin and mood changes: myth or reality? An updated overview. 2013 Int. J. Dermatol. pmid:21913911
Femia AN and Ann Vleugels R Toward improved understanding of a potential association between isotretinoin and inflammatory bowel disease. 2013 J. Invest. Dermatol. pmid:23486427
Etminan M et al. Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data. 2013 JAMA Dermatol pmid:23426479
Popescu CM and Bigby M The weight of evidence on the association of isotretinoin use and the development of inflammatory bowel disease. 2013 JAMA Dermatol pmid:23426480
Nya-Ngatchou JJ et al. Intratesticular 13-cis retinoic acid is lower in men with abnormal semen analyses: a pilot study. 2013 Andrology pmid:23413144
Park HC et al. Treatment of multiple eccrine hidrocystomas with isotretinoin followed by carbon dioxide laser. 2013 J. Dermatol. pmid:23414089
Aktürk AŞ et al. Effects of isotretinoin on serum vitamin E levels in patients with acne. 2013 Int. J. Dermatol. pmid:23414163
Alonso-de-Celada RM and de-Lucas Laguna R Safe and successful treatment of acne vulgaris with isotretinoin in a patient with chronic granulomatous disease. 2012 Sep-Oct Pediatr Dermatol pmid:21966949
Ramió Montero E et al. [Isotretinoin associated with risk of suicide]. 2012 Sep-Oct Farm Hosp pmid:22266200
Bansal M et al. Basal cell nevus syndrome: a rare entity. 2012 Sep-Oct Indian J Dermatol Venereol Leprol pmid:22960843
Sarifakioglu E et al. Terminal hematuria associated with oral isotretinoin treatment in a patient with acne vulgaris. 2012 Sep-Oct Pediatr Dermatol pmid:22067016
Konjevic G et al. In vitro increased natural killer cell activity of metastatic melanoma patients with interferon-α alone as opposed to its combination with 13-cis retinoic acid is associated with modulation of NKG2D and CD161 activating receptor expression. 2012 Oct-Dec J BUON pmid:23335538
Rallis E and Korfitis C Isotretinoin for the treatment of granulomatous rosacea: case report and review of the literature. 2012 Nov-Dec J Cutan Med Surg pmid:23149202
D'Erme AM et al. Treatment of refractory subacute cutaneous lupus erythematosus with oral isotretinoin: a valid therapeutic option. 2012 May-Jun Dermatol Ther pmid:22913448
Vieira AS et al. The effect of isotretinoin on triglycerides and liver aminotransferases. 2012 May-Jun An Bras Dermatol pmid:22714752
Pachajoa H and Ordoñez A [Isotretinoin embryopathy with microtia-anotia and congenital heart disease: case report]. 2012 May-Jun Arch Argent Pediatr pmid:22760759
Goyal T et al. Familial atrophia maculosa varioliformis cutis: first case report from the Indian subcontinent with pedigree analysis. 2012 Mar-Apr Indian J Dermatol Venereol Leprol pmid:22421651
Shiva G et al. Improved photostability, reduced skin permeation and irritation of isotretinoin by solid lipid nanoparticles. 2012 Acta Pharm pmid:23333889
Mundi JP et al. Dissecting cellulitis of the scalp. 2012 Dermatol. Online J. pmid:23286798
Hu SW et al. Morbihan disease. 2012 Dermatol. Online J. pmid:23286817
Gruber R et al. An appraisal of oral retinoids in the treatment of pachyonychia congenita. 2012 J. Am. Acad. Dermatol. pmid:21601946
Miljkovic J A novel therapeutic approach to plane warts: a report on two cases. 2012 Acta Dermatovenerol Alp Pannonica Adriat pmid:23267875
Ergun T et al. Isotretinoin has no negative effect on attention, executive function and mood. 2012 J Eur Acad Dermatol Venereol pmid:21545542
Ismailogullari S et al. Effects of isotretinoin treatment on sleep in patients with severe acne: a pilot study. 2012 J Eur Acad Dermatol Venereol pmid:21545544
Palatsi R et al. [New insights in the pathogenesis and treatment of rosacea]. 2012 Duodecim pmid:23342479
Larson DL et al. Does systemic isotretinoin inhibit healing in a porcine wound model? 2012 Aesthet Surg J pmid:23110930
Yook JH et al. Pregnancy outcomes and factors associated with voluntary pregnancy termination in women who had been treated for acne with isotretinoin. 2012 Clin Toxicol (Phila) pmid:23116253
Levinson M et al. Sacroiliitis secondary to isotretinoin. 2012 Australas. J. Dermatol. pmid:23157782
Javanbakht AM et al. Effects of oral isotretinoin on serum folic acid levels. 2012 J Drugs Dermatol pmid:23135667
Requena C et al. Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin. 2012 Cutis pmid:22988651
Gardner CR et al. Synthesis of retinoid enhancers based on 2-aminobenzothiazoles for anti-cancer therapy. 2012 Bioorg. Med. Chem. pmid:23088909
Moysidis SN et al. Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside. 2012 Mediators Inflamm. pmid:23049173
Truong A et al. Native American skin offerings mistaken for acne scars in a college undergraduate. 2012 Arch Dermatol pmid:23069975
Masetti R et al. Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma. 2012 Adv Ther pmid:22941525
Mehra T et al. Treatment of severe acne with low-dose isotretinoin. 2012 Acta Derm. Venereol. pmid:22377969
Wang QF et al. [The preparation and kinetic study on enzymatically-controlled drug release of isotretinoin/amylose inclusion complex]. 2012 Yao Xue Xue Bao pmid:23227555
Yoo BH et al. A high-content assay to identify small-molecule modulators of a cancer stem cell population in luminal breast cancer. 2012 J Biomol Screen pmid:22751729
Crijns I et al. Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies. 2012 Drug Saf pmid:22050373
Sharow KA et al. Retinoic acid stability in stem cell cultures. 2012 Int. J. Dev. Biol. pmid:22562202
Xu L et al. Spatiotemporal manipulation of retinoic acid activity in zebrafish hindbrain development via photo-isomerization. 2012 Development pmid:22874920
Dahan A et al. The fraction dose absorbed, in humans, and high jejunal human permeability relationship. 2012 Mol. Pharm. pmid:22524707
Maatouk I et al. Narrowband ultraviolet B phototherapy associated with improvement in Netherton syndrome. 2012 Clin. Exp. Dermatol. pmid:22582910
Szumiło J et al. [Chemoprevention of oral cancer--clinical and experimental studies]. 2012 Pol. Merkur. Lekarski pmid:22590920
Crisà E et al. Long-term follow-up of myelodysplastic syndrome patients with moderate/severe anaemia receiving human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3: independent positive impact of erythroid response on survival. 2012 Br. J. Haematol. pmid:22571649
Hildebrandt MA et al. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention. 2012 Clin. Cancer Res. pmid:22577058
Sinclair W The rational use of systemic isotretinoin: a call for moderation. 2012 S. Afr. Med. J. pmid:22554330
Thiboutot D et al. Oral isotretinoin and pregnancy prevention programmes. 2012 Br. J. Dermatol. pmid:21985025
Uslu M et al. Rosacea treatment with intermediate-dose isotretinoin: follow-up with erythema and sebum measurements. 2012 Acta Derm. Venereol. pmid:21952746
Cyrulnik AA et al. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life. 2012 Int. J. Dermatol. pmid:22909370
Cras A et al. Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer. 2012 Clin. Cancer Res. pmid:22142826
Dalirsani Z et al. The effects of 5-fluorouracil alone and in combination with 13-cis retinoic acid and vitamin D3 on human oral squamous cell carcinoma lines. 2012 J Contemp Dent Pract pmid:22918008
Sharma J et al. The effects of isotretinoin on wisdom tooth extraction. 2012 J. Am. Acad. Dermatol. pmid:22980255
Merklen-Djafri C et al. [Folliculosebaceous cystic hamartoma: anatomo-clinical study]. 2012 Ann Dermatol Venereol pmid:22225739
Pasmatzi E et al. Large benign condyloma acuminatum: successful treatment with isotretinoin and interferon alpha. 2012 Acta Derm. Venereol. pmid:22113200
Crijns HJ et al. Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study. 2012 Pharmacoepidemiol Drug Saf pmid:22228673
Bergler-Czop B and Brzezińska-Wcisło L The new therapy schema of the various kinds of acne based on the mucosa-skin side effects of the retinoids. 2012 Cutan Ocul Toxicol pmid:22103810
Pili R et al. Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours. 2012 Br. J. Cancer pmid:22134508
Ormerod AD et al. Influence of isotretinoin on hippocampal-based learning in human subjects. 2012 Psychopharmacology (Berl.) pmid:22193726
Traynor K REMS review explores programs' burdens. 2012 Am J Health Syst Pharm pmid:22215349
Snyder R and Thekkumkara T 13-cis-Retinoic acid specific down-regulation of angiotensin type 1 receptor in rat liver epithelial and aortic smooth muscle cells. 2012 J. Mol. Endocrinol. pmid:22180636
Derungs A et al. [Possible aggravation of a Henoch Schoenlein purpura by isotretinoin]. 2012 Praxis (Bern 1994) pmid:22715073
Yesilova Y et al. Effects of isotretinoin on obsessive compulsive symptoms, depression, and anxiety in patients with acne vulgaris. 2012 J Dermatolog Treat pmid:21815780
Yesilova Y et al. Effects of isotretinoin on social anxiety and quality of life in patients with acne vulgaris: a prospective trial. 2012 Acta Dermatovenerol Croat pmid:22726279
Pérez-Pérez L et al. Optic neuritis probably induced by isotretinoin. 2012 Actas Dermosifiliogr pmid:22748299
Gerber PA et al. Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients. 2012 Eur. J. Med. Res. pmid:22472354
Neudorfer M et al. Ocular adverse effects of systemic treatment with isotretinoin. 2012 Arch Dermatol pmid:22508771
Cumurcu T et al. Changes in anterior chamber parameters with the Pentacam rotating Scheimpflug and axial length measurements by ultrasound in patients who use isotretinoin. 2012 Curr. Eye Res. pmid:22510008
Dispenza MC et al. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. 2012 J. Invest. Dermatol. pmid:22513780
Bettoni CC et al. Isotretinoin-loaded nanocapsules: stability and cutaneous penetration by tape stripping in human and pig skin. 2012 J Biomed Nanotechnol pmid:22515077
Karadag AS et al. Immunoregulatory effects of isotretinoin in patients with acne. 2012 Br. J. Dermatol. pmid:22435970
Misery L et al. [Isotretinoin and adolescent depression]. 2012 Ann Dermatol Venereol pmid:22325750
Picosse FR et al. Early chemabrasion for acne scars after treatment with oral isotretinoin. 2012 Dermatol Surg pmid:22687256
Seneschal J et al. Exogenous inflammatory acne due to combined application of cosmetic and facial rubbing. 2012 Dermatology (Basel) pmid:22653048
Zapletalova D et al. Metronomic chemotherapy with the COMBAT regimen in advanced pediatric malignancies: a multicenter experience. 2012 Oncology pmid:22538363
Erturan Ä° et al. Isotretinoin treatment induces oxidative toxicity in blood of patients with acne vulgaris: a clinical pilot study. 2012 Cell Biochem. Funct. pmid:22517509
Erpolat S et al. Isotretinoin associated anal fissure and rectal bleeding: a rare complication. 2012 Int. J. Dermatol. pmid:22348579
Sato Y et al. 13-cis-retinoic acid-associated bone marrow edema in neuroblastoma. 2012 Pediatr Blood Cancer pmid:22354520
Ballester Sánchez R et al. [Increase in creatine phosphokinase and a suicide attempt during isotretinoin treatment]. 2012 An Pediatr (Barc) pmid:22361045
Landis ET et al. Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey. 2012 J Dermatolog Treat pmid:22380867
Cheung NK et al. Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission. 2012 J. Clin. Oncol. pmid:22869886
Hartung B et al. Severe generalised rhabdomyolysis with fatal outcome associated with isotretinoin. 2012 Int. J. Legal Med. pmid:22895802
Karadag AS et al. Does isotretinoin therapy have any effects on electrocardiography, heart rate and blood pressure? 2012 J Dermatolog Treat pmid:21254889